Data is currently being updated. Some features may be temporarily unstable.

Disease Profile

Bacterial

Legionellosis

军团菌病

Legionellosis is a bacterial respiratory infection caused by Legionella species, ranging from a mild influenza-like illness to severe pneumonia. The disease is primarily acquired through inhalation of contaminated water aerosols from artificial water systems, with Legionella pneumophila being the predominant causative agent worldwide. Surveillance data indicate approximately 10-15 cases per million annually in regions with established reporting systems, though true global burden remains uncertain due to diagnostic limitations.

Definition

Legionellosis is an infectious disease caused by exposure to Legionella bacteria, which are naturally present in freshwater environments and potting mixes. The term encompasses both pneumonic and non-pneumonic forms of infection, with Legionnaires' disease representing the severe pulmonary manifestation. Legionella pneumophila is the species most commonly responsible for human illness and was first identified in 1977 as the etiologic agent of a 1976 pneumonia outbreak among convention attendees in Philadelphia, USA.

Clinical features

Legionellosis presents along a severity spectrum from mild febrile illness to life-threatening pneumonia. The non-pneumonic form, known as Pontiac fever, manifests as an acute, self-limiting influenza-like illness lasting two to five days, characterized by fever, chills, headache, malaise, and myalgia, with an incubation period of up to 48 hours and no associated mortality. Legionnaires' disease, the pneumonic form, has an incubation period of two to ten days and presents with initial symptoms including fever, loss of appetite, headache, lethargy, and myalgia, progressing to include cough, shortness of breath, and gastrointestinal symptoms such as nausea, vomiting, and diarrhea. The majority of exposures do not result in clinical illness.

Epidemiology

Legionellosis occurs worldwide, though reported incidence varies substantially based on surveillance capacity and diagnostic capabilities. In Europe, Australia, and the United States, approximately ten to fifteen cases per million population are detected annually, while the true global burden remains undefined due to inadequate diagnostic methods and surveillance systems in many countries. Cases are classified epidemiologically as community-acquired, travel-associated, or hospital-acquired based on exposure context. Among reported cases, seventy-five to eighty percent occur in individuals over fifty years of age, and sixty to seventy percent are male.

Transmission

The primary route of transmission is inhalation of aerosols containing Legionella bacteria from contaminated water sources. Artificial water systems serve as the most common vehicle for human infection, including air conditioning cooling towers, hot and cold water systems, humidifiers, and whirlpool spas. Transmission may also occur through aspiration of contaminated water or ice, particularly among hospitalized patients, and through exposure during water births. Direct person-to-person transmission has not been documented, though the infective dose is unknown and presumed to be low for susceptible individuals.

Risk groups

Advanced age represents the most significant risk factor for severe Legionellosis, with the majority of cases occurring in individuals over fifty years. Male sex is associated with higher reported incidence for reasons that remain incompletely understood. Behavioral risk factors include smoking and heavy alcohol consumption, while underlying conditions conferring elevated risk encompass chronic pulmonary disease, immunosuppression, and chronic respiratory or renal illness. Hospitalized patients are at particular risk for healthcare-associated infection through aspiration of contaminated water or ice.

Prevention

Prevention relies on proper maintenance of water systems to inhibit Legionella growth and aerosol generation. The bacteria proliferate at temperatures between twenty and fifty degrees Celsius, with optimal growth at thirty-five degrees, and are inactivated at temperatures exceeding sixty degrees Celsius. Control measures include maintaining appropriate water temperatures, regular cleaning and disinfection of potential amplification sites such as cooling towers and hot water systems, and minimizing aerosol generation where possible. No vaccine is currently available for Legionellosis prevention.

Surveillance note

Legionellosis surveillance is complicated by variable diagnostic capacity across jurisdictions and the non-specific clinical presentation of the disease. Underreporting is substantial in regions lacking urinary antigen testing capability or mandatory reporting requirements. Surveillance systems should account for case categorization by exposure setting, as this informs outbreak investigation and source attribution. Temporal clusters or geographic aggregations of severe pneumonia cases, particularly among older adults with recent travel or healthcare exposure, warrant specific Legionella testing.

Coding Register
ICD-10
ICD-11
Key Statistics
Total cases
76K
Peak month
2018-10
Coverage
3 reporting countries · 2000-01-01 → 2026-05-09

Figure 1 | Full historical trajectories across all reporting countries.

Figure 2 | Year-over-year monthly comparison for seasonality and structural shifts.

Dataset Archive

Supplementary Data | Multi-country disease dataset

Machine-readable multi-country disease dataset (JSON/CSV) with source metadata.

Rows
2,089
Data Version
2026-05-09
Coverage
Included metadata
Source links, scope, cadence

Source Register

Official sources and update cadences used to construct the downloadable dataset.

AU
Australia NINDSSmonthlymicrosoft_bi

Australia

Australian national notifiable diseases surveillance dashboard.

Official source
JP
JP NIID Weeklyweeklyweb

Japan

Japan weekly infectious disease surveillance via NIID/JIHS.

Official source
US
US CDC NNDSSweeklyapi

United States

CDC National Notifiable Diseases Surveillance System provisional data.

Official source
Suggested presentation pattern: cite the data version and coverage window when exporting charts or tables for publication.